Medpace Q4 2022 Financial Results | Investor Presentation

Medpace Holdings presents Q4 2022 financial results with forward-looking statements and non-GAAP financial measures including EBITDA and free cash flow analysis. The clinical research organization discusses performance metrics, operational strategies, and risk factors affecting its biopharmaceutical CRO business.